The Israel Economic Mission invites you to engage with the best and brightest minds from Israel and the Bay Area at the world's first biotech accelerator, IndieBio. Listen to industry leaders' key insights on venture and corporate investments in biotech. Israel's Chief Scientist, Avi Hasson, will give the keynote speech covering the landscape of the Israeli biotech economy. Between the panels, twenty of Israel's established and emerging biotech firms will present one minute pitches on the latest advancements in their fields. Check out the speakers below:
IndieBio is devoted to funding and building biotech startups dedicated toward solving humanity’s most pressing problems with Life itself. They're committed to building a future where biology is not only a field of study, but a technology that will help solve our culture’s most challenging problems. From feeding a growing population, to providing energy and rare inputs for our increasingly connected economies, to treating or curing the maladies that limit or kill us, Biotech promises us solutions we’ve only dreamed of in the past.
IndieBio is short for Independent Biology, a new way for scientists, entrepreneurs, and tinkerers to shape their own destiny and make something that matters. At Indie.bio, we provide seed funding and intensive mentorship to drive this transition in only three months, then launch our graduate companies into the world of biotechnology to make their fortune, buffered by our many partners and alumni and ready to excel.
The Israel Office of the Chief Scientist (OCS) is tasked to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’s scientific potential, and enhancing the knowledge base of industry in Israel. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.
SOSV began supplying startups with rocket fuel 20 years ago. They are now a global fund with $250M assets under management and a staff of nearly 60 operating world-renowned accelerators in the areas of hardware, software, biology, food, robotics, medical devices, transportation, green energy, and beyond. With over 400 companies in their portfolio, they will graduate over 150 startups from our accelerator programs in 2016.
Immune System Key is engaged in discovery and development of innovative treatments for malignant and autoimmune diseases with strong unmet needs. Its assets are based on novel human secreted peptides, which were discovered by the founders. ISK’s lead compound NerofeTM was granted by the FDA with orphan drug status for AML treatment.
Kadimastem is a leading regenerative medicine company focused on the industrial development and commercialization of stem cell-based therapeutics, primarily for diabetes and neurodegenerative disorders.
The company’s proprietary technologies and know-how enable the differentiation of stem cells into insulin secreting beta cells as well as a range of neural cells.
MyBiotics focus is to return the bacterial population to its healthy and balanced state by using live bacteria that will colonize and compete with the existent disease-promoting population.The company is currently focusing on an initial set of indications including C. difficle, post-antibiotic microbiome restoration and side effect reduction and anti-inflammation.
NovellusDx is dedicated to delivering the actionable intelligence that oncologists require to choose the right therapy for each patient. NovellusDx provides comprehensive, fully-automated, functional gene profiling of individual patient tumors including charting the full landscape of known and unknown mutations that drive the cancer’s progression.
Nucleix Ltd. develops, manufactures, and markets innovative non-invasive molecular cancer diagnostic tests. Our highly sensitive and specific tests are based on identification of subtle changes in methylation patterns. Nucleix technology is based on a combination of a new biochemical platform in conjunction with sophisticated algorithms.
The Government of Israel Economic Mission to the West Coast is responsible for enhancing bi-national trade relations between the West Coast and Israeli business communities. The main fields of activity include promoting trade and exports, attracting and encouraging foreign investments and creating strategic cooperation with foreign companies. By leveraging its networking capacity and industry knowledge in Israel and the Western United States, the Economic Mission is able to seamlessly engage prospective business partners half a world apart.
